AlphaStocks
3.9
Weak

Stryker Corp (SYK)

As of Sep 20, 2026, Stryker Corp (SYK) scores 3.9/10 on AlphaStocks' five-model composite, #141 of 168 Health Care stocks. At $275, SYK trades 25% below its model fair value of $367.

Health Care / Health Care Equipment

S&P 500

$274.95

Scores poorly across most models. Proceed with caution.

Weak

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#141out of 168 in Health Care

Is STRYKER CORP a Good Investment in 2026?

STRYKER CORP (SYK) scores 3.9 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates STRYKER CORP as Attractive (6/9). However, the Graham model rates it Caution — Significantly above fair value. STRYKER CORP currently trades 25% below its estimated fair value of $367. STRYKER CORP ranks #141 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E21.7ROE22.1Market Cap106BDiv Yield1.0

Estimated Fair Value

$366.6425% below

Trading below estimated fair value. EPS grew 32% year-over-year. ROE of 22% signals strong profitability. P/E of 22x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Neutral

PEG 3.2 · Stalwart

Greenblatt

Attractive

Earnings yield 5.4% · ROC 69%

Frequently Asked Questions

Is STRYKER CORP (SYK) a good investment?
As of Sep 20, 2026, Stryker Corp (SYK) scores 3.9/10 on AlphaStocks' five-model composite, #141 of 168 Health Care stocks. At $275, SYK trades 25% below its model fair value of $367. That score is below average, suggesting caution.
What is STRYKER CORP's Piotroski F-Score?
STRYKER CORP's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is SYK overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $367, SYK appears undervalued. The stock currently trades 25% below its estimated fair value. Trading below estimated fair value. EPS grew 32% year-over-year. ROE of 22% signals strong profitability. P/E of 22x is moderate for this quality level.
How does SYK compare to other Health Care stocks?
STRYKER CORP ranks #141 out of 168 stocks in the Health Care sector, placing it in the top 84% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about SYK?
AlphaStocks evaluates SYK using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 3.9/10.

Similar Stocks

INSPUFPTBDX

Compare SYK with

INSP vs SYKSYK vs UFPTBDX vs SYKFTI vs SYKPARR vs SYKSYK vs VAL

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer